Skip to main content

Treating claudication and rest pain due to chronic total occlusion of the SFA

Case takeaways

  • As demonstrated in this case, the GORE® VIABAHN® Endoprosthesis offers excellent patency in the treatment of long SFA total occlusions and should be considered first-line treatment for complex SFA disease

The GORE® VIABAHN® Endoprosthesis has demonstrated durability and long-term patency in treatment of complex SFA disease with 97% three-year secondary patency (27 cm average lesion length, 93% CTOs)1
  1. GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface [Instructions for Use]. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2014. MD147177.

This content is for informational purposes only, is not advice or a guarantee of outcome. It is not a substitute for professional medical advice, diagnosis or treatment. Individual results and/or treatment may vary based upon the circumstances, the patient’s specific situation, and the healthcare provider’s medical judgment.

Visit our clinical uses page